Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03793920
Other study ID # 2015_76
Secondary ID 2017-A00843-50
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date November 8, 2018
Est. completion date November 11, 2022

Study information

Verified date September 2022
Source University Hospital, Lille
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Hypothesis: Individuals presenting with prenatal alcohol exposure (PEA) show emotional abilities deficits, and imbalance between the two systems involved in decision-making according to dual-process models, namely an under-activated reflective system (involved in deliberate behaviors) and an over-activated affective-automatic one (involved in impulsive behaviors). Primary objective: To explore performance (as a percentage of correct answers) in an emotional facial expression decoding task in PEA participants compared to controls without alcohol disorder.


Description:

Each participant will undergo 2 visits : First visit : - Checking inclusion and non-inclusion criteria - Note of information and consent form - Record of concomitant treatments and anamnestic elements - Alcohol, Tobacco, and Toxic Consumption - Urinary Toxicity Test for Control Groups - Laterality test (Hecaen, 1984) - Brief visual and auditory acuity test - Standardized psychiatric interview (Mini International Neuropsychiatric Interview - MINI) Second visit = Experimental testing - State-Trait Anxiety Inventory, Beck Depression Inventory, Inventory of Interpersonal Problems, Toronto Alexithymia Scale (TAS-20). - Participant installation and testing: 6 behavioral tasks on a computer (also used to collect responses, except for task 2, see details below) : Task 1 (MAIN): Test for recognition of facial emotions Task 2: 'Reading the Mind in the Eyes Test' (Decoding of complex emotional states) Task 3: Emotional evaluation of natural scenes Task 4: Target detection (measure of attentional bias towards alcohol-related stimuli) Task 5: Go / No-Go evaluating the interactions between inhibition processes and auto-affective system Task 6: "N-back" evaluating the interactions between working memory and automatic-affective system


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 144
Est. completion date November 11, 2022
Est. primary completion date November 11, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - Man or woman aged between 18 and 60 years - Able to understand and to speak French - Able to understand Note of information and to sign consent form - Available health insurance - Normal (or corrected to normal) vision and audition - For women: Negative pregnancy test or menopausal for at least one year - For Group 1 only : PEA criteria and no alcohol consumption within the three days preceding the experiment. - For Group 2 only : PEA criteria, diagnosed with severe alcohol addiction and currently abstinent (for at least 15 days). - For Group 3 only : Non-alcohol-dependent controls. No alcohol consumption within the three days preceding the experiment and father diagnosed with severe alcohol addiction. - For Group 4 only : Non-alcohol-dependent controls. No alcohol consumption within the three days preceding the experiment. Exclusion Criteria: - Refusal of participation after clear and fair information on the study. - Visual or auditory sensory disability to participate in the study. - Benzodiazepines and / or Antipsychotic concomitant treatment. - History of (or current) neurologic disease - History of (or current) psychiatric disorder (apart alcohol-dependence for the PEA-alcohol-dependent group) - Psychoactive Substance Use or Abuse other than tobacco and alcohol. - Pregnant or breast-feeding women. - Underage (<18 yo) or adults under guardianship, judicial protection, or deprived of liberty.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Facial Emotion Test
All tasks will be delivered using a laptop and E-Prime 2 software (Psychology Software Tools, Inc., Pittsburgh), which will also be used to collect behavioral responses.

Locations

Country Name City State
France CHRU Lille, Fontan2 Lille
France CSAPA Lille

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Lille

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Percentage of correct answers of an emotional facial expression (EFE) Performance of an emotional facial expression (EFE) decoding task in EPA subjects and compare it to non-alcohol dependent controls one day
Secondary Psychopathological assessment by Mini International Neuropsychiatric Interview MINI Presence of psychiatric disorders by a standardized psychiatric interview one day
Secondary Percentage of correct answers ant latency of behavioral answers Performance of behavioral tasks one day
Secondary State-Trait-Anxiety Inventory (STAI) score Score at STAI STAI is a psychological inventory based on a 4-point Likert scale and consists of 40 questions on a self-report basis one day
Secondary Beck Depression Inventory score Score at Beck Depression Inventory The BDI consisted of twenty-one questions about how the subject has been feeling in the last week. Each question had a set of at least four possible responses, ranging in intensity. (0) I do not feel sad/ (1) I feel sad./ (2) I am sad all the time and I can't snap out of it/ (3) I am so sad or unhappy that I can't stand it.
When the test is scored, a value of 0 to 3 is assigned for each answer and then the total score is compared to a key to determine the depression's severity. The standard cut-off scores were as follows:0-9: indicates minimal depression/ 10-18: indicates mild depression/ 19-29: indicates moderate depression/ 30-63: indicates severe depression.
one day
Secondary Toronto Alexithymia Scale TAS-20 score Score at TAS-20 The Toronto Alexithymia Scale is a measure of deficiency in understanding, processing, or describing emotions. The current version has twenty statements rated on a five-point Likert scale. ( range : Strongly disagree/Disagree/ Neither agree nor disagree/ Agree/ Strongly agree) one day
See also
  Status Clinical Trial Phase
Completed NCT01911299 - Choline Supplementation in Children With Fetal Alcohol Spectrum Disorders Phase 2
Completed NCT03633149 - Choices4Health: Intervention to Prevent Substance-exposed Pregnancy N/A
Completed NCT01149538 - Postnatal Choline Supplementation in Children With Prenatal Alcohol Exposure Phase 1/Phase 2